CEFODIZIME SODIUM PDF

Cefodizime Sodium ≥96% (HPLC); CAS Number: ; Synonym: 5-Thia azabicyclo[]octenecarboxylic acid. Cefodizime Sodium is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cefodizime Sodium is available on the. The first dose of cefodizime in patients with impaired renal function is the . The sodium content of cefodizime (75 mg/g) should be taken into.

Author: Akitaur Mazutaxe
Country: Ukraine
Language: English (Spanish)
Genre: Business
Published (Last): 14 February 2014
Pages: 111
PDF File Size: 17.99 Mb
ePub File Size: 17.41 Mb
ISBN: 299-3-73613-610-1
Downloads: 81724
Price: Free* [*Free Regsitration Required]
Uploader: Jumuro

Ceforanide The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Ceforanide. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. Pentostatin Cefotaxime may decrease the excretion rate of Pentostatin which could result in a higher serum level. Mofebutazone The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Mofebutazone.

Cefotaxime

Azelaic acid Cefotaxime may decrease the excretion rate of Azelaic acid which could result in a higher serum level. Don’t have an account? Dabigatran etexilate Cefotaxime may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level. Pentaerythritol tetranitrate Cefotaxime may decrease the excretion rate of Pentaerythritol Tetranitrate which could result in a higher serum level.

Fentiazac The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Fentiazac. Valganciclovir Cefotaxime may decrease the excretion rate of Valganciclovir which could result in a higher serum level. Fosinopril Cefotaxime may decrease the excretion rate of Fosinopril which could result in a higher serum level. It has similar adverse effect profile to other 3rd generation cephalosporins as well, mainly being limited to gastrointestinal or dermatological side effects.

  EPSON ACULASER M2000DN PDF

Zalcitabine The excretion of Zalcitabine can be decreased when combined with Cefotaxime. Allylestrenol Cefotaxime may decrease the excretion rate of Allylestrenol which could result in a higher serum level. Gentamicin C1a The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Gentamicin C1a.

Cefodizime Sodium

Oxacillin Cefotaxime may decrease the excretion rate of Oxacillin which could result in a higher serum level. Warfarin Cefotaxime may decrease the excretion rate of Warfarin which could result in a higher serum level. Ethadione The therapeutic efficacy of Ethadione can be decreased when used in combination with Cefotaxime.

Tenecteplase The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotaxime. Call us Toll Free at Prasugrel Cefotaxime may decrease the excretion rate of Prasugrel which could result in a higher serum level.

Temazepam Cefotaxime may decrease cefodizije excretion rate of Temazepam which could result in a higher serum level. Leucovorin The excretion of Leucovorin can be decreased when combined with Cefotaxime. Digoxin Cefotaxime sosium decrease the excretion rate of Digoxin which could result in a higher serum level.

Tixocortol Cefotaxime may decrease the excretion rate of Tixocortol which could result in a higher serum level. Meperidine Cefotaxime may decrease the excretion rate of Meperidine which could result in a higher serum level. Oseltamivir Cefotaxime may decrease the excretion rate of Oseltamivir which could result in a higher serum level.

Amobarbital The therapeutic efficacy of Amobarbital can be decreased when used in combination with Cefotaxime.

Trimebutine Cefotaxime may decrease the excretion rate of Trimebutine which could result in a higher serum level. Certoparin The therapeutic efficacy of Certoparin can be decreased when used in combination with Cefotaxime.

Morniflumate The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Morniflumate.

  HP 4339B PDF

Cefadroxil Cefotaxime may decrease the excretion rate of Cefadroxil which could result in a higher serum level. Cefpiramide The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Cefotaxime.

Cefodizime sodium | CAS | SCBT – Santa Cruz Biotechnology

Octinoxate Cefotaxime may decrease the excretion rate of Octinoxate which could result in a higher serum level. Tolterodine Cefotaxime may decrease the excretion rate of Tolterodine which could result in a higher serum level. Reteplase The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotaxime. Levetiracetam The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Cefotaxime. Rosiglitazone Cefotaxime may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.

Bacillus calmette-guerin substrain danish live antigen The therapeutic efficacy of Bacillus calmette-guerin substrain danish live antigen can be decreased when used in combination with Cefotaxime.

Cephalosporin antibiotics Acetic acids Thiazoles Ketoximes. Doramectin The therapeutic efficacy of Doramectin can be decreased when used in combination with Cefotaxime.

Evening primrose oil Cefotaxime may decrease the excretion rate of Evening primrose oil which could result in a higher serum level. Amantadine Cefotaxime may decrease the excretion rate of Amantadine which could result in a higher serum level.

Cefodizzime Cefotaxime may decrease the excretion rate of Selenium which could result in a higher serum level. Subscribe to receive email notifications whenever new articles are published.